Abstract
5-Fluorouracil (5-FU) is the most commonly used therapy and the conventional treatment for colorectal cancer. However, its toxicity to normal tissues is considered a major obstacle to successful cancer chemotherapy; thus, resveratrol is used in combination with 5-FU to reduce its toxicity. The goal of our study is to investigate the mechanisms underlying the effects of resveratrol alone and in combination with 5-FU in inhibiting experimentally induced colon cancer. Rats were divided into eight groups including control, resveratrol, 5-FU, resveratrol with 5FU, N-methylnitrosourea, treated group 1, 2, and 3 groups. Oxidant/antioxidant parameters, plasma NF-κB, and real-time PCR quantification of colonic P53 gene expression were assessed. Histopathological and immunohistochemistry of cyclooxygenases (COX-1, COX-2) were also performed. The data showed that N-methylnitrosourea significantly increased colon malondialdehyde (MDA), advanced oxidation protein products (AOPP), and nuclear factor-κB (NF-κB) concomitant with a reduction in superoxide dismutase (SOD) and a downregulation in P53 gene expression. Supplementation with resveratrol improved these values in treated groups. Thus, resveratrol is a highly promising antioxidant, anti-cancer, and anti-inflammatory compound through activating antioxidant defense system, its direct scavenging activity, as well as its biological activities through downregulation of COX-2 via suppression of NF-κB activation.
Similar content being viewed by others
References
Abdallah IZA, Khattab HAH, Heeba GH (2011) Gastroprotective effect of Cordia myxa L. fruit extract against indomethacin-induced gastric ulceration in. RatsLife Sci J 8(3):433–445
Asao T, Takayuki A, Shibata HR, Batist G, Brodt P (1992) Eradication of hepatic metastases of carcinoma H-59 combination chemoimmunotherapy with liposomal muramyltripeptide, 5-fluorouracil and leucovorin. Cancer Res 52:6254–6257
Bio-Rad Laboratories Inc (2006) Real-time PCR obesity: evidence and mechanisms. Nutr. Rev., applications guide. Bulletin 5279:101
Bishayee A (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila) 2:409–418
Cersosimo RJ (2013) Management of advanced colorectal cancer, part 1. Am J Health Syst Pharm 70(5):395–406
Chang CT, Ho TY, Lin H, Liang JA, Huang HC et al (2012) 5-Fluorouracil induced intestinal mucositis via nuclear factor-kB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One 7(3):e31808
Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV (2018) Combination of resveratrol and 5-fluorouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9(68):32943–32957. https://doi.org/10.18632/oncotarget25993 eCollection 2018 Aug 31
Culling CFA (1974) Handbook of histopathological and histochemical techniques, 3rd edn. Butterworth and Company, London, pp 126–159
Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287:L774–L783
Eshak MG, Ghaly IS, Khalil WKB, Farag IM, Ghanem KZ (2010) Genetic alterations induced by toxic effect of thermally oxidized oil and protective role of tomatoes and carrots in mice. J Am Sci 6(4):175–188
Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663–673
Frombaum M, Clanche SL, Bonnefont-Rousselot D, Borderie D (2012) Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and ·NO bioavailability: potential benefits to cardiovascular diseases. Biochimie 94:269–276
Harrison S, Benziger H (2011) The molecular biology of colorectal carcinoma and its implications: a review. Surgeon 9(4):200–210
Hussein J, El-Khayat Z, Farrag A, Medhat D, Abdel Latif Y, Oraby F (2014) Inhibition of hyperhomocysteinemia in indomethacin induced peptic ulcer: impact of pomegranate juice supplementation. J Chem Pharm Res 6(10):131–138
Hussein J, Refaat E, Medhat D, El-Bana M, Abdel Latif Y, Farrag A, Nazeef N, Moify M (2016) Panax ginseng attenuates experimental brain injury by increasing brain derived neurotrophic factor and inhibition of neuro-inflammation. J Chem Pharm Res 8(1):186–195
Issa JP (2008) Colon cancer: it’s CIN or CIMP. Clin Cancer Res 14:5939–5940
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220
Karin M (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339–27342
Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309:1017–1026
Longley DB, Harkin DP, Johnston PG (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338
Lopez-Velez M, Martinez-Martinez F, Del Valle-Ribes C (2003) The study of phenolic compounds as natural antioxidants in wine. Crit Rev Food Sci Nutr 43:233–244
Meng Y, Ma Q-Y, Kou X-P, Xu J (2005) Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. World J Gastroenterol 11(4):525–528
Narisawa T, Fukaura Y (2003) Prevention by intrarectal 5-aminosalicylic acid of N-methylnitrosourea-induced colon cancer in F344 rats. Dis Colon Rectum 46(7):900–903
Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K et al (2009) Results of a phase I pilot clinical trial examining the effect of plant derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1:25–37
Nishikimi M, Roa NA, Yogi K (1972) Measurement of superoxide dismutase. Biochem Biophys Res Commun 46:849–854
Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D et al (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392–7399
Patton C, Crouch S (1977) Spectrophotometric and kinetic investigation of the berthelot reaction for the determination pf ammonia. J Anal Chem 49:464–469
Pervaiz S (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17:1975–1985
Raftery L, Goldberg RM (2010) Optimal delivery of cytotoxic chemotherapy for colon cancer. Cancer J 16(3):214–219
Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28(1):56–63
Rivera H, Shibayama M, Tsutsumi V, Perez-Alvarez V, Muriel P (2008) Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J Appl Toxicol 28:147–155
Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Kayama T, Kitanaka C (2013) Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells. Stem Cell Res 11:601–610
Schmatz R, Perreira LB, Stefanello N, Mazzanti C, Spanevello R, Gutierres J, Bagatini M, Martins CC, Abdalla FH, da Silva Serres JD, Zanini D, Vieira JM, Cardoso AM, Schetinger MR, Morsch VM (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374–383
Sharma SH, Kumara JS, Chellappan DR, Nagarajan S (2018) Molecular chemoprevention by morin—a plant flavonoid that targets nuclear factor kappa B in experimental colon cancer. Biomed Pharmacother 100:367–373
Siemann EH, Creasy LL (1992) Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43:49–52
Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145–182
Soliman RH, Ismail OA, Badr MS, Nasr SM (2017) Resveratrol ameliorates oxidative stress and organ dysfunction in Schistosoma mansoni infected mice. Exp Parasitol 174:52–58
Takaoka MJ (1940) The phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). J Facult Sci Hokkaido Imp Univ 3:1–16
Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G (2012) The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 22(11):557–566
Uchiyamara M, Mihara M (1978) Determination of malondialdehyde in tissue by thiobarbituric acid test. Anal Biochem 86:271–278
Van den Heuvel SJ, Van Laar T, Kast WM, Melief CJ, Zantema A, Van der Eb AJ (1990) Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J 9:2621–2629
Violette S, Laurent Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T (2002) Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-XL in addition to Bax and p53 status. Int J Cancer 98:498–504
Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F, Moldawer LL, Camp ER, MacKay SLD (2004) Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res 120:178–188
Wolter F, Ulrich S, Stein J (2004) Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? J Nutr 134:3219–3222
Worthley DL, Leggett BA (2010) Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev 31:31–38
Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, Pan CE (2004) Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 10(20):3048–3052
Yar AS, Menevse Alp SE (2011) The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genet Mol Res 10(4):2962–2975
Yazbeck R, Lindsay R, Catherine AA, Benkendorff K, Gordon SH (2015) Combined effects of muricid extract and 5-fluorouracil on intestinal toxicity in rats. Evid Based Complement Alternat Med 2015, Article ID 170858:1–9
Young DS (2001) Effect of disease on clinical laboratory test, 4th edn. AACC
Zordoky BN, Robertson IM, Dyck JR (2015) Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 1852:1155–1177
Acknowledgments
The authors acknowledge the National Research Centre (NRC), Giza, Egypt, for providing necessary facilities for accomplishment of this research work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical clearance
Prior ethical clearance for experimentation was approved by the National Research Centre (NRC), Giza, Egypt. In all the experimentation, the ethical care and treatment of the animals were conducted as per the guidelines laid down and following the regulations of the ethical committee of NRC.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abdel Latif, Y., El-Bana, M., Hussein, J. et al. Effects of resveratrol in combination with 5-fluorouracil on N-methylnitrosourea-induced colon cancer in rats. Comp Clin Pathol 28, 1351–1362 (2019). https://doi.org/10.1007/s00580-019-02967-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-019-02967-2